| Flotillin-1 | |
|---|---|
| Protein Name | Flotillin-1 |
| Gene | FLOT1 |
| UniProt ID | O75955 |
| PDB Structures | 2MA7 |
| Molecular Weight | 47 kDa |
| Subcellular Localization | Membrane rafts |
| Protein Family | Flotillin family |
Flotillin-1 (also known as FLOT1) is a 47 kDa integral membrane protein that localizes to lipid rafts, specialized microdomains in the plasma membrane enriched in cholesterol and sphingolipids. As a member of the flotillin family (which includes Flotillin-1 and Flotillin-2), this protein plays essential roles in membrane organization, signal transduction, and cellular communication. Flotillin-1 is ubiquitously expressed with high levels in neuronal tissue, where it accumulates at synaptic membranes and is involved in neurotransmitter receptor trafficking and neuronal signaling pathways relevant to neurodegenerative diseases[1].
Flotillin-1 is encoded by the FLOT1 gene located on chromosome 6p21.3. The protein forms hetero-oligomeric complexes with Flotillin-2 in lipid rafts, creating scaffold platforms that organize signaling molecules and membrane proteins. In the nervous system, flotillins are enriched in synapses and have been implicated in the regulation of amyloid precursor protein (APP) processing, dopamine signaling, and neuronal survival mechanisms. Dysregulation of flotillin expression and lipid raft integrity has been linked to the pathogenesis of both Alzheimer's disease (AD) and Parkinson's disease (PD)[2].
Flotillin-1 is a 47 kDa protein belonging to the Flotillin family. The protein contains:
Flotillin-1 forms heterooligomers with Flotillin-2, creating large membrane-associated complexes of approximately 2-5 MDa that constitute the core structure of lipid rafts[3].
Flotillin-1 is a lipid raft-associated protein involved in membrane organization and signal transduction. It forms microdomains that concentrate signaling molecules. Specific functions include:
Flotillin-1 plays a complex role in Alzheimer's disease pathogenesis:
In Parkinson's disease, flotillin-1 is implicated through:
Flotillin-1 dysregulation has been reported in:
The study of Flotillin 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Flotillin-1 in neuronal signaling and neurodegenerative disease (2020). 2020. ↩︎
Lipid rafts and Alzheimer's disease pathogenesis (2019). 2019. ↩︎
Flotillin heterooligomer formation and lipid raft organization (2018). 2018. ↩︎
Flotillin-1 regulates AMPA receptor trafficking in hippocampal neurons (2021). 2021. ↩︎